• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.69% Nasdaq Down2.17%

    Karyopharm Therapeutics, Inc. (KPTI)

    -NasdaqGS
    7.28 Down 0.24(3.19%) 10:29AM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue -   25   75   150  
    Cost of Revenue -   -   -   -  
    Gross Profit -   25   75   150  
    Operating Expenses
    Research Development21,795  24,064  25,923  27,006  
    Selling General and Administrative5,554  5,264  4,762  6,157  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (27,349) (29,303) (30,610) (33,013)
    Income from Continuing Operations
    Total Other Income/Expenses Net290  257  237  318  
    Earnings Before Interest And Taxes(27,059)(29,046)(30,373)(32,695)
    Interest Expense -   -   -   -  
    Income Before Tax(27,059)(29,046)(30,373)(32,695)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(27,059)(29,046)(30,373)(32,695)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (27,059) (29,046) (30,373) (32,695)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (27,059) (29,046) (30,373) (32,695)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.